Hisamitsu Pharmaceutical (4530 JP): Strong Result, New Drug Launch, & Share Buyback Brighten Outlook
In Q1FY24 Hisamitsu recorded double-digit top-line and triple-digit bottom-line growth, driven by Salonpas. The company launched 2 drugs in Japan...
630 Views
Weekly Deals Digest (15 Feb) - Hisamitsu, Takara Bio, Toyota Ind, Mandom, Dongfeng, Pepper Money
A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...
260 Views
Hisamitsu Pharma (4530 JP): Risk/Reward as Shares Trade Through Terms
The probability of a bump is low due to no visible activism, peers not re-rating, irrevocables, several crossholders, and the minimum can be...
317 Views
Asia-Pac M&A, Jan 2026 Wrap: Hisamitsu Pharma, IJM Corp, Sankei Real Estate, BioDlink, Skyworth
For the month of Jan 2026, 6 new deals were discussed on Smartkarma with an overall deal size of ~US$8bn. The average premium for these new deals...
320 Views
Asia-Pac M&A Weekly Wrap: Bluescope Steel, Iress, Skyworth, Toyota Inds., Raksul, Sankei Real Estate
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
417 Views